Price Alert

Belite Bio Inc (BLTE)

NASDAQ: BLTE · Real-Time Price · USD

63.42

1.61 (2.60%)

At close: Aug 20, 2025, 3:59 PM

62.20

-1.92%

After-hours: Aug 20, 2025, 04:18 PM EDT

Belite Bio Inc Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	May 31, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	n/a	31.68M	n/a	95.5M	95.5M	88.16M	54.5M	57.4M	37.8M	42.09M	42.09K	48.7K	-17.34M	17.34M	17.34M	21.99M	21.99M
Short-Term Investments	n/a	113.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.69M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.91M	103K	4.55M	4.57M	4.68M	166K	1.46M	1.56M	1.4M	57K	-1.35K	1.13M	-17.34M	823K	823K	11K	11K
Receivables	n/a	594K	n/a	n/a	n/a	867K	n/a	n/a	n/a	19K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	698.28K	n/a	n/a	n/a	n/a	-5.75K	-5.75K	-5.75K
Other Current Assets	159.29M	n/a	111.27M	18.36M	968K	n/a	1.64M	59.14M	38.42M	n/a	718.00	1.23M	n/a	n/a	23K	20K	20K
Total Current Assets	159.29M	147.07M	111.27M	113.86M	96.47M	89.94M	56.13M	59.14M	38.42M	42.81M	42.81K	49.93M	17.34M	17.43M	17.43M	22.04M	22.04M
Property-Plant & Equipment	n/a	965K	n/a	n/a	n/a	1.3M	n/a	n/a	n/a	1.38M	1.35K	n/a	n/a	94K	94K	114K	114K
Goodwill & Intangibles	n/a	3.99M	n/a	n/a	n/a	3.23M	n/a	n/a	n/a	31K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.91M	5.06M	4.55M	4.57M	4.68M	4.7M	1.46M	1.56M	1.4M	1.47M	1.35K	1.13M	-17.34M	917K	917K	125K	125K
Total Assets	164.2M	152.13M	115.82M	118.43M	101.15M	94.64M	57.6M	60.7M	39.82M	44.27M	44.27K	51.06M	n/a	18.35M	18.35M	22.17M	22.17M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	276K	n/a	n/a	n/a	308K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.13M	716K	3.62M	3.84M	4.68M	-159K	4.8M	n/a	n/a	74K	2.1K	n/a	n/a	24K	95K	15K	15K
Total Current Liabilities	6.13M	6.05M	3.62M	3.84M	4.68M	3.63M	4.8M	4.98K	4.65M	2.1M	2.1K	1.43K	n/a	1.64M	1.64M	997K	997K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	31.81M	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	261K	n/a	n/a	4.68M	578K	4.8M	4.98M	n/a	668K	n/a	1.43M	n/a	31.81M	7.95M	7.95M	7.95M
Total Liabilities	6.13M	6.31M	3.62M	3.84M	4.68M	4.21M	4.8M	4.98M	4.65M	2.77M	2.77K	1.43M	n/a	33.44M	1.64M	997K	997K
Total Debt	n/a	537K	n/a	n/a	n/a	886K	n/a	n/a	n/a	866K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	158.07M	3K	112.2M	114.59M	96.47M	3K	52.79M	55.72K	35.17K	3K	3.00	49.63K	n/a	1K	1K	1K	1K
Retained Earnings	n/a	-107.65M	n/a	n/a	n/a	-71.5M	n/a	n/a	n/a	-39.87M	-39.87K	n/a	n/a	-27.22M	-27.22M	-22.28M	-22.28M
Comprehensive Income	n/a	-660K	n/a	n/a	n/a	-374K	n/a	n/a	n/a	-392K	n/a	n/a	-15.09M	-196K	-196K	-131K	-131K
Shareholders Equity	158.07M	145.82M	112.2M	114.59M	96.47M	90.43M	52.79M	55.72M	35.17M	41.5M	41.5K	49.63M	16.71M	-15.09M	16.71M	21.17M	21.17M
Total Investments	n/a	113.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.69M	n/a	n/a	n/a	n/a